Burkitt's lymphoma differential diagnosis

Burkitt's lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Burkitt's lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study Of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray Findings
CT
MRI
Biopsy
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Burkitt's lymphoma differential diagnosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Burkitt's lymphoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Burkitt's lymphoma differential diagnosis
CDC on Burkitt's lymphoma differential diagnosis
Burkitt's lymphoma differential diagnosis in the news
Blogs on Burkitt's lymphoma differential diagnosis
Directions to Hospitals Treating Burkitt's lymphoma
Risk calculators and risk factors for Burkitt's lymphoma differential diagnosis

Assistant Editor-in-Chief: Soumya Sachdeva

It ,sometimes , becomes very difficult for the pathologist to differentiate between burkitt's lymphoma and diffuse large B cell lymphoma.They can be differentiated only by the fact that there is a very high proliferative fraction seen in patients with burkitt's lymphoma(i.e.,essentially 100% of tumor cells are in cycle) caused by c-myc deregulation.

References

Template:WikiDoc Sources